MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 350M 700M 1.1B Q4 '20: 284.1M Q1 '21: 381.3M Q2 '21: 552.2M Q3 '21: 669.1M Q4 '21: 799.2M Q1 '22: 895.3M Q2 '22: 920.3M Q3 '22: 906.7M Q4 '22: 883M Q1 '23: 717.7M Q2 '23: 543.9M Q3 '23: 419.5M Q4 '23: 288.9M Q1 '24: 274.1M Q2 '24: 274.6M Q3 '24: 276.8M Q4 '24: 259.2M Q1 '25: 241.9M Q2 '25: 219.8M Q3 '25: 192.4M Q4 '25: 185.7M Q1 '26: 204.7M Q2 '26: 208.8M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 25M 50M 75M Q2 '25: 67.1M Q3 '25: 40.5M Q4 '25: 34M Q1 '26: 60M Q2 '26: 72.8M Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Income TTM

-500M -250M 0 250M 500M 750M Q4 '20: 119.9M Q1 '21: 176.3M Q2 '21: 321.7M Q3 '21: 431.3M Q4 '21: 554.6M Q1 '22: 630.8M Q2 '22: 658M Q3 '22: 619.5M Q4 '22: 574.2M Q1 '23: 409.4M Q2 '23: 217.1M Q3 '23: 84.7M Q4 '23: -31.6M Q1 '24: -53M Q2 '24: -54.9M Q3 '24: -205.1M Q4 '24: -235.6M Q1 '25: -265.9M Q2 '25: -318.8M Q3 '25: -194.2M Q4 '25: -215.3M Q1 '26: -168.3M Q2 '26: -117.1M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-270M -180M -90M 0 90M 180M 270M Q4 '20: 89M Q1 '21: 88.7M Q2 '21: 136.4M Q3 '21: 151.4M Q4 '21: 182M Q1 '22: 225.8M Q2 '22: 247.9M Q3 '22: 238.4M Q4 '22: 220.2M Q1 '23: 153.3M Q2 '23: 75.5M Q3 '23: 24.6M Q4 '23: -119M Q1 '24: -131M Q2 '24: -134.3M Q3 '24: -224.9M Q4 '24: -144.8M Q1 '25: -162.7M Q2 '25: -192.5M Q3 '25: -121M Q4 '25: -130.8M Q1 '26: -104.6M Q2 '26: -77.4M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 60M 120M 180M Q4 '20: 79.6M Q1 '21: 95.7M Q2 '21: 112.4M Q3 '21: 124.8M Q4 '21: 140.6M Q1 '22: 149.2M Q2 '22: 148.9M Q3 '22: 154.8M Q4 '22: 169M Q1 '23: 162.6M Q2 '23: 168.4M Q3 '23: 166.9M Q4 '23: 148.7M Q1 '24: 153.4M Q2 '24: 148.7M Q3 '24: 148.8M Q4 '24: 150.9M Q1 '25: 151.7M Q2 '25: 152.7M Q3 '25: 151.9M Q4 '25: 151.8M Q1 '26: 144.8M Q2 '26: 135.9M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-200M 0 200M 400M 600M Q4 '20: 152.2M Q1 '21: 180.8M Q2 '21: 335.1M Q3 '21: 389.3M Q4 '21: 368.6M Q1 '22: 492.5M Q2 '22: 490.9M Q3 '22: 495.4M Q4 '22: 536M Q1 '23: 458.7M Q2 '23: 313.7M Q3 '23: 217.8M Q4 '23: 126.2M Q1 '24: 32.7M Q2 '24: 30.9M Q3 '24: 29.9M Q4 '24: 7.5M Q1 '25: 6.5M Q2 '25: -21.2M Q3 '25: -49.4M Q4 '25: -57.6M Q1 '26: -39.5M Q2 '26: -25.3M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-200M 0 200M 400M 600M Q4 '20: 126.8M Q1 '21: 155.5M Q2 '21: 308.3M Q3 '21: 371.2M Q4 '21: 353.7M Q1 '22: 478.3M Q2 '22: 479.5M Q3 '22: 478.9M Q4 '22: 518.9M Q1 '23: 436.5M Q2 '23: 268.1M Q3 '23: 162.8M Q4 '23: 60.7M Q1 '24: -30.7M Q2 '24: -16.9M Q3 '24: -10.7M Q4 '24: -22.2M Q1 '25: -22M Q2 '25: -43M Q3 '25: -66.3M Q4 '25: -70.7M Q1 '26: -52.6M Q2 '26: -35.8M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 90M 180M 270M Q1 '20: 253.9M Q2 '20: 253.9M Q3 '20: 253.9M Q1 '21: 96.7M Q2 '21: 112.3M Q3 '21: 258M Q1 '22: 255.3M Q2 '22: 255.4M Q3 '22: 131.7M Q1 '23: 131.7M Q2 '23: 131.9M Q3 '23: 131.9M Q1 '24: 132.3M Q2 '24: 135.8M Q3 '24: 141.6M Q1 '25: 143.4M Q2 '25: 144.2M Q3 '25: 144.7M Q1 '26: 146.4M Q2 '26: 148M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-3.00 -1.50 0.00 1.50 3.00 4.50 Q4 '20: 2.36 Q1 '21: 2.51 Q2 '21: 2.95 Q3 '21: 3.27 Q4 '21: 1.55 Q1 '22: 1.81 Q2 '22: 1.90 Q3 '22: 1.80 Q4 '22: 1.67 Q1 '23: 1.17 Q2 '23: 0.59 Q3 '23: 0.20 Q4 '23: -0.90 Q1 '24: -0.99 Q2 '24: -1.01 Q3 '24: -1.64 Q4 '24: -1.02 Q1 '25: -1.14 Q2 '25: -1.34 Q3 '25: -0.84 Q4 '25: -0.90 Q1 '26: -0.71 Q2 '26: -0.52 Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.